196 related articles for article (PubMed ID: 28572600)
1. A nucleotide-controlled conformational switch modulates the activity of eukaryotic IMP dehydrogenases.
Buey RM; Fernández-Justel D; Marcos-Alcalde Í; Winter G; Gómez-Puertas P; de Pereda JM; Luis Revuelta J
Sci Rep; 2017 Jun; 7(1):2648. PubMed ID: 28572600
[TBL] [Abstract][Full Text] [Related]
2. The Bateman domain of IMP dehydrogenase is a binding target for dinucleoside polyphosphates.
Fernández-Justel D; Peláez R; Revuelta JL; Buey RM
J Biol Chem; 2019 Oct; 294(40):14768-14775. PubMed ID: 31416831
[TBL] [Abstract][Full Text] [Related]
3. Guanine nucleotide binding to the Bateman domain mediates the allosteric inhibition of eukaryotic IMP dehydrogenases.
Buey RM; Ledesma-Amaro R; Velázquez-Campoy A; Balsera M; Chagoyen M; de Pereda JM; Revuelta JL
Nat Commun; 2015 Nov; 6():8923. PubMed ID: 26558346
[TBL] [Abstract][Full Text] [Related]
4. A Nucleotide-Dependent Conformational Switch Controls the Polymerization of Human IMP Dehydrogenases to Modulate their Catalytic Activity.
Fernández-Justel D; Núñez R; Martín-Benito J; Jimeno D; González-López A; Soriano EM; Revuelta JL; Buey RM
J Mol Biol; 2019 Mar; 431(5):956-969. PubMed ID: 30664871
[TBL] [Abstract][Full Text] [Related]
5. Diversity of mechanisms to control bacterial GTP homeostasis by the mutually exclusive binding of adenine and guanine nucleotides to IMP dehydrogenase.
Fernández-Justel D; Marcos-Alcalde Í; Abascal F; Vidaña N; Gómez-Puertas P; Jiménez A; Revuelta JL; Buey RM
Protein Sci; 2022 May; 31(5):e4314. PubMed ID: 35481629
[TBL] [Abstract][Full Text] [Related]
6. The gateway to guanine nucleotides: Allosteric regulation of IMP dehydrogenases.
Buey RM; Fernández-Justel D; Jiménez A; Revuelta JL
Protein Sci; 2022 Sep; 31(9):e4399. PubMed ID: 36040265
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure at 2.4 A resolution of Borrelia burgdorferi inosine 5'-monophosphate dehydrogenase: evidence of a substrate-induced hinged-lid motion by loop 6.
McMillan FM; Cahoon M; White A; Hedstrom L; Petsko GA; Ringe D
Biochemistry; 2000 Apr; 39(15):4533-42. PubMed ID: 10758003
[TBL] [Abstract][Full Text] [Related]
8. Insight into the role of the Bateman domain at the molecular and physiological levels through engineered IMP dehydrogenases.
Gedeon A; Ayoub N; Brûlé S; Raynal B; Karimova G; Gelin M; Mechaly A; Haouz A; Labesse G; Munier-Lehmann H
Protein Sci; 2023 Aug; 32(8):e4703. PubMed ID: 37338125
[TBL] [Abstract][Full Text] [Related]
9. Increased riboflavin production by manipulation of inosine 5'-monophosphate dehydrogenase in Ashbya gossypii.
Buey RM; Ledesma-Amaro R; Balsera M; de Pereda JM; Revuelta JL
Appl Microbiol Biotechnol; 2015 Nov; 99(22):9577-89. PubMed ID: 26150243
[TBL] [Abstract][Full Text] [Related]
10. A novel cofactor-binding mode in bacterial IMP dehydrogenases explains inhibitor selectivity.
Makowska-Grzyska M; Kim Y; Maltseva N; Osipiuk J; Gu M; Zhang M; Mandapati K; Gollapalli DR; Gorla SK; Hedstrom L; Joachimiak A
J Biol Chem; 2015 Feb; 290(9):5893-911. PubMed ID: 25572472
[TBL] [Abstract][Full Text] [Related]
11. MgATP regulates allostery and fiber formation in IMPDHs.
Labesse G; Alexandre T; Vaupré L; Salard-Arnaud I; Him JL; Raynal B; Bron P; Munier-Lehmann H
Structure; 2013 Jun; 21(6):975-85. PubMed ID: 23643948
[TBL] [Abstract][Full Text] [Related]
12. Different characteristics and nucleotide binding properties of inosine monophosphate dehydrogenase (IMPDH) isoforms.
Thomas EC; Gunter JH; Webster JA; Schieber NL; Oorschot V; Parton RG; Whitehead JP
PLoS One; 2012; 7(12):e51096. PubMed ID: 23236438
[TBL] [Abstract][Full Text] [Related]
13. In cellulo crystallization of Trypanosoma brucei IMP dehydrogenase enables the identification of genuine co-factors.
Nass K; Redecke L; Perbandt M; Yefanov O; Klinge M; Koopmann R; Stellato F; Gabdulkhakov A; Schönherr R; Rehders D; Lahey-Rudolph JM; Aquila A; Barty A; Basu S; Doak RB; Duden R; Frank M; Fromme R; Kassemeyer S; Katona G; Kirian R; Liu H; Majoul I; Martin-Garcia JM; Messerschmidt M; Shoeman RL; Weierstall U; Westenhoff S; White TA; Williams GJ; Yoon CH; Zatsepin N; Fromme P; Duszenko M; Chapman HN; Betzel C
Nat Commun; 2020 Jan; 11(1):620. PubMed ID: 32001697
[TBL] [Abstract][Full Text] [Related]
14. A regulatory role of the Bateman domain of IMP dehydrogenase in adenylate nucleotide biosynthesis.
Pimkin M; Pimkina J; Markham GD
J Biol Chem; 2009 Mar; 284(12):7960-9. PubMed ID: 19153081
[TBL] [Abstract][Full Text] [Related]
15. Reciprocal alterations of GMP reductase and IMP dehydrogenase activities during differentiation in HL-60 leukemia cells.
Nakamura H; Natsumeda Y; Nagai M; Takahara J; Irino S; Weber G
Leuk Res; 1992; 16(6-7):561-4. PubMed ID: 1353130
[TBL] [Abstract][Full Text] [Related]
16. A potent "fat base" nucleotide inhibitor of IMP dehydrogenase.
Wang W; Hedstrom L
Biochemistry; 1998 Aug; 37(34):11949-52. PubMed ID: 9718319
[TBL] [Abstract][Full Text] [Related]
17. Inosine 5'-monophosphate dehydrogenase binds nucleic acids in vitro and in vivo.
McLean JE; Hamaguchi N; Belenky P; Mortimer SE; Stanton M; Hedstrom L
Biochem J; 2004 Apr; 379(Pt 2):243-51. PubMed ID: 14766016
[TBL] [Abstract][Full Text] [Related]
18. Crystallographic studies of two variants of Pseudomonas aeruginosa IMPDH with impaired allosteric regulation.
Labesse G; Alexandre T; Gelin M; Haouz A; Munier-Lehmann H
Acta Crystallogr D Biol Crystallogr; 2015 Sep; 71(Pt 9):1890-9. PubMed ID: 26327379
[TBL] [Abstract][Full Text] [Related]
19. First-in-class allosteric inhibitors of bacterial IMPDHs.
Alexandre T; Lupan A; Helynck O; Vichier-Guerre S; Dugué L; Gelin M; Haouz A; Labesse G; Munier-Lehmann H
Eur J Med Chem; 2019 Apr; 167():124-132. PubMed ID: 30769241
[TBL] [Abstract][Full Text] [Related]
20. A structural determinant of mycophenolic acid resistance in eukaryotic inosine 5'-monophosphate dehydrogenases.
Freedman R; Yu R; Sarkis AW; Hedstrom L
Protein Sci; 2020 Mar; 29(3):686-694. PubMed ID: 31675145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
